Escola São Paulo de Ciência Avançada em Vacinas


A Escola visa proporcionar aos participantes uma visão crítica e abrangente do estado da arte na pesquisa de vacinas, começando com temas básicos, como "impacto global da vacinação" e aprofundando a temas mais complexos, como "vacinologia de sistemas". Em geral, o programa científico abordará os seguintes temas: importância e impacto das vacinas na saúde pública, imunidade inata e adaptativa, adjuvantes, vacinas convencionais e novas estratégias de vacinação, sistemas de fornecimento de antígenos, testes clínicos/clínicos e vacinologia de sistemas.

O programa de palestras ministradas por pesquisadores internacionalmente renomados inclui temas de pesquisa para o desenvolvimento de vacinas contra patógenos de grande importância, como os que causam malária, AIDS, dengue, Zika e Chikungunya.

Os organizadores propõem a seleção de 80 estudantes, 40 dos quais devem ser preenchidos por candidatos de fora do Brasil. Os alunos selecionados terão a oportunidade de apresentar os resultados de sua pesquisa em sessões de pôsteres e palestras por 10 minutos. Haverá benefícios para hospedar os alunos selecionados provenientes do exterior e de outras cidades do Brasil fora da cidade que hospeda o evento.

  • Intituição

    Faculdade de Ciências Farmacêuticas - USP

  • Área de conhecimento

    Farmácia

  • Pesquisador Responsável

    Irene da Silva Soares

  • Nº do Processo FAPESP

    2017/17349-7

  • Período

    22/11/2018 a 02/12/2018

  • Inscrições

    01/02/2018 a 01/06/2018

  • Site

    http://vaccinology.school/how-to-apply/

  • Cidade

    São Paulo

  • Palavras-chave

    Vacinas, Imunologia, Saúde

  • Programa Ocultar

    PALESTRANTES

    Rino Rappuoli

    Rino Rappuoli is Chief Scientist & Head of External Research and Development (R&D) at GlaxoSmithKline (GSK) Vaccines. He is known globally for his work in vaccines and immunology. He co-founded the field of cellular microbiology, a discipline combining cell biology and microbiology, and pioneered the genomic approach to vaccine development known as reverse vaccinology.

    Michel Nussenzweig

    Dr. Nussenzweig is a Full Professor at the Rockefeller University at New York and head of the Laboratory of Molecular Immunology. He is also a Howard Hughes Medical Institute Investigator since 1999, and member of the US National Academy of Sciences, National Academy of Medicine, American Academy of Arts and Sciences and Brazilian Academy of Sciences. His laboratory currently studies the molecular aspects of the immune system’s innate and adaptive responses using a combination of biochemistry, molecular biology, and genetics. For work on adaptive immunity, the focus is on B lymphocytes and antibodies to HIV-1, while the studies of innate immunity focus on dendritic cells.

    Takafumi Tsuboi

    Dr. Tsuboi has a Doctor of Medicine degree from the School of Medicine at the Ehime University where in 1986 he obtained a Ph.D. in parasitology. In 1997 he became Associate Professor at the Department of Parasitology of the Ehime University, and in 2003 he became Professor at the Cell-free Science and Technology Research Center at the same university. Since 2013 he is a Professor at the Division of Malaria Research and is the Director of the Proteo-Science Center, Ehime University, Japan. His laboratory uses cell-free protein expression technology to study malarial antigens.

    Gabriel Victora

    Dr. Victora obtained Bachelor and Master of Music degrees from the Mannes College of Music. In 2006 he obtained a Master of Science in immunology at the University of Sao Paulo and in 2011 a Ph.D. in immunology at the New York University. He was a Whitehead Fellow at the Whitehead Institute for Biomedical Research from 2012 to 2016. Since 2016 he is an Assistant Professor at the Rockefeller University and head of the Laboratory of Lymphocyte Dynamics. In 2017 he was awarded the MacArthur Genius Grant. His laboratory studies how antibodies are formed.

    Daniela Ferreira

    Dr. Ferreira obtained a Bachelor of Science in biomedical sciences in 2005 and a Ph.D. in Immunology and Biotechnology in 2009 from the University of Sao Paulo. In 2006 she was awarded the Robert Austrian Research Award in Pneumococcal Vaccinology to develop novel mucosal vaccines. In 2015 she was appointed Senior Lecturer at the Department of Clinical Sciences of the Liverpool School of Tropical Medicine in UK. Her laboratory uses a method of inducing pneumococcal carriage in human volunteers to research host immune responses to pneumococcal carriage.

    Steven Reed

    Dr. Reed is the Founder, President, and CEO of the Infectious Disease Research Institute, based in Seattle, USA. His academic appointments include Professor of Medicine at Cornell University Medical College in New York and Research Professor of Pathobiology at the University of Washington. His research interests have focused on the immunology of intracellular infections, the development of vaccines and diagnostics for both cancer and infectious diseases (Tuberculosis and Leishmaniasis).

    Denise da Fonseca

    Dr. Fonseca has a Ph.D. in immunology in 2006 from the University of Sao Paulo. From 2012 to 2016 she was a postdoctoral fellow at the Laboratory of Parasitic Diseases of the National Institute of Health. Since 2016 she is a FAPESP Young Researcher at the Department of Immunology of the Institute of Biomedical Sciences, University of Sao Paulo. In 2016 she was awarded the prize L’Oréal-UNESCO For Women in Science. Her laboratory studies the interactions of mucosal immunity and the gut microbiota.

    Esper Kallás

    Dr. Kallás graduated in Medicine in 1989. In 1996, he obtained a Master’s degree, and in 1999, a Ph.D. in Infectology from the Federal University of São Paulo. Since 2009, he is an Associate Professor at the University of São Paulo School of Medicine. He is also a Researcher at the Laboratory of Clinical Immunology and Allergy (LIM-60), where he carries out translational medicine projects, bringing basic science concepts to clinical applications, especially in infectious diseases.

    Jorge Kalil

    Dr. Kalil is currently a Full Professor of Clinical Immunology and Allergy at the University of São Paulo School of Medicine, Director of the Laboratory of Immunology at the Heart Institute and Former Director of the Butantan Institute. Also, Dr. Kalil was president of the IUIS (International Union of Immunology Societies) from 2013 to 2016. His laboratory currently focuses on HLA, autoimmunity, organ transplantation, auto-infectious immunity and allergies.

    Edécio Cunha-Neto

    Dr. Cunha Neto completed his post-doctorate/visiting research internships at the Universities of Stanford (1991) and Harvard (2002), and at the Instituto Roche Milano Ricerche in Italy (1996). In 2001, he became an Associate Professor at the University of São Paulo School of Medicine. He is currently chief of the Laboratory of Clinical Immunology and Allergy (LIM-60) and vice-coordinator of the Research Support Center of the Institute of Immunology Research (INCTiii). His laboratory focuses on translational research in the areas of cellular and molecular immunology of human diseases, with emphasis on the immunopathology of chronic Chagas' heart disease and HIV-1 infection.

    Daniela Santoro Rosa

    Dr. Rosa obtained her Ph.D. in Microbiology, Immunology and Parasitology from the Federal University of São Paulo in 2006. Since 2010, she is a Professor at the Department of Microbiology, Immunology and Parasitology of the Federal University of São Paulo. Her laboratory is interested in the development and evaluation of new vaccine candidates for HIV, Zika and Chikungunya, and also studies the effect of sleep deprivation on immunity.

    Luís Carlos Ferreira

    Dr. Ferreira is the current Director of the Biomedical Sciences Institute at University of São Paulo. As head of the Vaccine Development Laboratory, his research interests focus on the development of different vaccine strategies for dengue, dental caries, tumors induced by papilloma virus and diarrhea diseases caused by enteric bacteria.

    Oscar Bruna-Romero

    Dr. Bruna-Romero obtained his PhD degree at the University of Navarra, Spain. He completed post-doctoral internships in Spain (ISCIII - Ministry of Health) in 1998 and USA (New York University) in 2001. He was a Visitant Researcher at FIOCRUZ, Brazil from 2001 to 2004, when joined Federal University of Minas Gerais, Brazil as an Assistant Professor. Currently, he is an Associate Professor at the Federal University of Santa Catarina with research interests focused on Immunology and Microbiology towards the development of recombinant vaccines (viral vectors) against infectious diseases.

    Santuza Teixeira

    Dr. Teixeira is Full Professor at the Federal University of Minas Gerais, member of the Brazillian INCT (CNPq) for Vaccine development, Coordenator of the Center of Vaccine Technology in Vaccines, Brazil and has been ranked as 1B Researcher at CNPq, Brazil. Her research interests focus on Molecular Parasitology and Parasite Genomics to evaluate gene expression, parasite-host interactions, genetic variability and DNA repair in Trypanosoma cruzi.

    Maria Belio

    Dr. Bellio has a PhD degree in Biophysics at the Federal University of Rio de Janeiro, Brazil. She is Associate Professor and Head of Department of Immunology at the Federal University of Rio de Janeiro. Her research interests focus on Cellular Immunology aspects, such as antigen recognition by TCR, role of TLRs in the cytotoxic CD8+ T cell response against Trypanosomatides, MyD88-dependent signalling pathways in Th1 response, development of vaccines based on recombinant phages as vaccine vectors, B cell maturation, homeostasis of Treg cells and control mechanism for experimental colitis and ZIKV-specific immunity.

    Ana Paula Fernandes

    Dr. Fernandes has a PhD degree in Parasitology at the Federal University of Minas Gerais, Brazil in 1997. Currently, she is Full Professor at the Federal University of Minas Gerais and has been ranked as 1B Researcher at CNPq, Brazil. Her research interests focus on the development of diagnostics, molecular epidemiology, vaccine and treatment against infectious diseases as Leishmaniasis. Also, risk factors associated with hipercoagulation states have been investigated.

    Pedro Vasconcelos

    Dr Pedro Fernando da Costa Vasconcelos is the Director of the Instituto Evandro Chagas (IEC), in Para, Brazil. Experience in Microbiology, Tropical Medicine and Pathology, with emphasis on Virology, working on the following topics: dengue, yellow fever, hantavirus, rabies, as well as in epidemiology, molecular biology of viruses, pathogenesis, and description and characterization of new arboviruses, and neurosciences especially neuroinfections caused by arboviruses. More than 250 articles and 60 book chapters published in journals and scientific books in Brazil and abroad.